Month: January 2020

A single number helps Stanford data scientists find most dangerous cancer cells

01/29/2020

“Biomedical data scientists at the Stanford University School of Medicine have shown that the number of genes a cell uses to make RNA is a reliable indicator of how developed the cell is, a finding that could make it easier to target cancer-causing genes.” Click the button below to read the entire Article! Continue Reading…

Read More

SOSV Announces Launch of IndieBio New York

01/08/2020

A fantastic opportunity for life science startups in the New York area! “We’re doubling down on life sciences,” said Sean O’Sullivan, Managing General Partner of SOSV. “We are looking to bring what IndieBio has created for the California life science industry to the East Coast. New York is a great hub for life sciences research and financing, and will be…

Read More

Google Shows AI Can Spot Breast Cancer Better Than Doctors

01/06/2020

According to new research from Google Health, AI can more accurately detect breast cancer than physicians. “The technology’s reading of mammograms reduced both false positives, where healthy patients are mistakenly diagnosed with the disease, and false negatives, where the cancer is missed, the Alphabet Inc. unit said in a blog post on Wednesday. The system reduced false positives by…

Read More

New radiotracer offers opportunities for earlier intervention after heart attack

01/06/2020

“ Reston, VA–Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage. According to research published in the December issue of The Journal of Nuclear Medicine, 68Ga-FAPI-04 positron emission tomography (PET) can effectively image fibroblast activation after myocardial…

Read More

Meet with Christopher Kata and the TrialStat team (booth # 701), during SCOPE – Summit for Clinical Operations Execs, February 18th – 21st, in Orlando, Florida!

01/02/2020

Meet with Christopher Kata, Director of Sales & Marketing February 18th – 21st, 2020 at the SCOPE – Summit for Clinical Operations Executives in Orlando, Florida. Christopher and the TrialStat team are exhibiting in booth # 701. Christopher Kata, Director of Sales & Marketing905 999-1957ckata@trialstat.com Event: SCOPE – Summit for Clinical Operations Executives When: February…

Read More

Meet with Christopher Kata, during the MedTeq Innovation Summit in Montreal, Quebec.

01/02/2020

Meet with Christopher Kata, Director of Sales & Marketing January 13th to the 16th 2020 at the MedTeq Innovation Summit in Montreal, Quebec. Christopher Kata, Director of Sales & Marketing905 999-1957ckata@trialstat.com Event: MedTeq Innovation Summit When: January 13th – 16th, 2020 Where: Grand Quai du Port de Montréal, 200 de la Commune West Street, Montreal…

Read More